Transient visual anomalies associated with drug treatment for spastic colon.

Abstract	A case report revealing two previously unreported adverse side effects of meprobamate and tridihexethyl chloride (Milpath) drug therapy for a spastic colon is presented. The two previously unreported adverse effects are a diffuse loss of color discrimination and an increased time course to complete dark adaptation.
Authors	R A Applegate, T Soriano, C Perry, J Elam
Journal	Journal of the American Optometric Association (J Am Optom Assoc) Vol. 57 Issue 8 Pg. 604-6 (Aug 1986) ISSN: 0003-0244 [Print] United States
PMID	3489028 (Publication Type: Case Reports, Journal Article)
Chemical References	Quaternary Ammonium Compounds tridihexethyl Meprobamate
Topics	Colonic Diseases, Functional (drug therapy) Color Vision Defects (chemically induced) Female Humans Meprobamate (adverse effects) Middle Aged Quaternary Ammonium Compounds (adverse effects) Time Factors Vision Disorders (chemically induced, physiopathology) Visual Acuity (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!